Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Amanda B Payne1, Zunera Gilani1, Shana Godfred-Cato1

  • 1COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.

JAMA Network Open
|June 10, 2021
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) is rare but disproportionately affects minority children. Incidence was higher in Black, Hispanic, and Asian children compared to White children, especially those aged 5 and younger.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health surveillance

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious condition linked to SARS-CoV-2 infection.
  • Limited data exists on the population-based incidence of MIS-C.

Purpose of the Study:

  • To estimate the incidence of MIS-C per person-months in children under 21.
  • To determine MIS-C incidence relative to SARS-CoV-2 infections in the same age group.

Main Methods:

  • Utilized enhanced surveillance data from 7 US jurisdictions (April-June 2020).
  • Calculated incidence using census data and adjusted SARS-CoV-2 case counts.
  • Analyzed data stratified by race/ethnicity and age group (≤5, 6-10, 11-15, 16-20 years).

Main Results:

  • Reported 248 MIS-C cases; median age 8 years, 53.6% male.
  • Overall MIS-C incidence was 5.1 per 1,000,000 person-months.
  • Incidence was significantly higher in Black, Hispanic/Latino, and Asian children compared to White children.
  • Incidence per SARS-CoV-2 infection was 316 per 1,000,000 infections, also higher in minority groups.
  • Youngest children (≤5 and 6-10 years) exhibited the highest incidence rates.

Conclusions:

  • MIS-C is a rare but significant complication of SARS-CoV-2 infection.
  • Disparities in MIS-C incidence exist across racial/ethnic groups.
  • Further research is needed to understand these disparities and inform targeted public health strategies.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.0K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K